grant

Relapse after Discontinuation of Antipsychotics during Pregnancy (R-DAP study)

Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAILocation NEW YORK, UNITED STATESPosted 2 Mar 2020Deadline 31 Jan 2029
NIHUS FederalResearch GrantFY20250-11 years oldActive Follow-upAffective DisordersAntipsychotic AgentsAntipsychotic DrugsAntipsychoticsBenefits and RisksBipolar Affective PsychosisBipolar DisorderBirth WeightChildChild YouthChildren (0-21)Chronologic Fetal MaturityClinical ResearchClinical StudyControl GroupsDataDenmarkDeveloping fetusDiseaseDisorderDrugsExposure toFamilyFathersFetal AgeFetal DevelopmentFetusGestationGestational AgeHealthHigh Risk WomanHospital AdmissionHospitalizationInfanticideInpatientsKnowledgeLamictalLamiktalLi+ elementLithiumLong-Term EffectsMajor TranquilizersMajor Tranquilizing AgentsManic-Depressive PsychosisMaternal HealthMaternal MortalityMedicationMental HealthMental HygieneMeta-AnalysisMetabolicMetabolic DiseasesMetabolic DisorderMonitorMood DisordersMothersNeonatalNeuroleptic AgentsNeuroleptic DrugsNeurolepticsOutcomePatientsPerinatalPeripartumPharmaceutical PreparationsPopulationPostpartum PeriodPregnancyPregnant WomenPsychological HealthRecurrenceRecurrentRelapseResearch ResourcesResourcesRiskSample SizeSiblingsSourceSuicideSuicide attemptSwedenThesaurismosisTitrationsUnipolar DepressionWeight GainWeight IncreaseWomanactive comparatoractive comparison controlactive followupanti-depressant agentanti-depressant drugsanti-depressantsanti-depressive agentsat-risk femalesat-risk womenbefore conceptionbipolar affective disorderbipolar diseasebipolar illnessbipolar mood disorderbipolar patientsbipolar spectrumbody weight gainbody weight increasechildbearing agedrug/agentearly in pregnancyearly pregnanciesearly pregnancyearly stage of pregnancyexpectant motherexpectant womenexpecting motherexpecting womenexposed in uterofatal attemptfatal suicidefemales at high riskfertile agefetal exposurefollow upfollow-upfollowed upfollowuphealth of the motherhigh riskhigh risk femalesin uteroin utero exposureindividuals who are pregnantintent to dieintra-uterine environmental exposureintrauterine environmental exposurekidslamotriginemanic depressive disordermanic depressive illnessmaternal deathmaternal morbiditymetabolism disorderneonatal outcomenon fatal attemptnonfatal attemptnoveloffspringpeople who are pregnantperinatal periodperinatal phaseperinatal womenpopulation basedpost-partumpreconceptionpregnant femalespregnant motherspregnant peoplepregnant populationsprenatalprenatal exposureprenatally exposedpreventprevent relapsepreventingprior to conceptionrelapse preventionrelapse riskreproductive agereproductive yearssuicidal attemptsuicidal risksuicide risksuicidesthose who are pregnantunbornwomen at high riskwomen who are pregnantwt gainyoungster
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Project Summary
There is an increase in psychotropic medication use in women in their fertile ages. Due to concerns for the

developing fetus, half of women decide to discontinue their medication before- or at the beginning of pregnancy.

While the wish to avoid in utero medication exposure to the fetus is understandable, discontinuation of…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →